Lantheus Holdings, Inc.
Lantheus Holdings, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 499 | 359 | 382 | 696 | 939 | 913 | 866 | 757 | 718 | 714 | 614 | 414 | |||||
Accounts Receivable Net Current | 356 | 359 | 351 | 337 | 349 | 321 | 329 | 372 | 337 | 284 | 259 | 256 | |||||
Inventory Net | 61 | 65 | 62 | 62 | 69 | 68 | 71 | 71 | 70 | 64 | 56 | 52 | |||||
Income Taxes Receivable | 1 | 15 | 32 | - | - | 8 | - | - | - | - | - | - | |||||
Other Assets Current | 25 | 21 | 21 | 34 | 67 | 16 | 22 | 24 | 16 | 17 | 11 | 23 | |||||
Assets Of Disposal Group Including Discontinued Op… | 0 | 81 | 77 | 73 | - | 0 | 7 | 7 | 7 | 7 | 7 | 7 | |||||
Assets Current | 942 | 900 | 925 | 1,202 | 1,424 | 1,327 | 1,296 | 1,231 | 1,149 | 1,086 | 948 | 752 | |||||
Equity Securities Fv Ni And Without Readily Determ… | 58 | 42 | 46 | 45 | 30 | 39 | 159 | 116 | 139 | 0 | - | - | |||||
Notes And Loans Receivable Net Noncurrent | 92 | - | - | - | - | - | - | - | - | - | - | - | |||||
Property Plant And Equipment And Finance Lease Rig… | 158 | 164 | 164 | 158 | 181 | 177 | 170 | 158 | 150 | 147 | 140 | 130 | |||||
Intangible Assets Net Excluding Goodwill | 706 | 723 | 739 | 360 | 154 | 162 | 174 | 172 | 142 | 152 | 163 | 221 | |||||
Goodwill | 239 | 240 | 240 | 177 | 61 | 61 | 61 | 61 | 61 | 61 | 61 | 61 | |||||
Deferred Income Tax Assets Net | 89 | 109 | 107 | 138 | 169 | 170 | 145 | 151 | 139 | 150 | 152 | 134 | |||||
Other Assets Noncurrent | 62 | 50 | 54 | 36 | 36 | 44 | 46 | 49 | 51 | 55 | 56 | 39 | |||||
Assets | 2,347 | 2,227 | 2,276 | 2,116 | 2,055 | 1,980 | 2,050 | 1,940 | 1,831 | 1,651 | 1,522 | 1,338 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Long Term Debt Current | 1 | 1 | 1 | 1 | 1 | 1 | 565 | 1 | 1 | 1 | 1 | 0 | |||||
Accounts Payable Current | 46 | 43 | 66 | 41 | 45 | 35 | 45 | 50 | 38 | 41 | 37 | 39 | |||||
Business Combination Contingent Consideration Liab… | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Accounts Payable And Other Accrued Liabilities Cur… | 286 | 267 | 251 | 209 | 202 | 205 | 174 | 213 | 199 | 145 | 139 | 115 | |||||
Liabilities Of Disposal Group Including Discontinu… | 0 | 22 | 29 | 30 | - | 0 | - | - | - | - | - | - | |||||
Liabilities Current | 333 | 333 | 347 | 280 | 248 | 241 | 784 | 263 | 237 | 187 | 177 | 154 | |||||
Asset Retirement Obligations Noncurrent | 0 | 0 | 0 | 0 | 19 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | |||||
Long Term Debt And Capital Lease Obligations | 570 | 569 | 568 | 567 | 566 | 565 | 1 | 563 | 562 | 562 | 561 | 559 | |||||
Deferred Income Tax Liabilities Net | 54 | 54 | 55 | - | - | 0 | - | - | - | - | - | - | |||||
Business Combination Contingent Consideration Liab… | 73 | 73 | 71 | - | - | 0 | - | - | - | - | - | - | |||||
Other Liabilities Noncurrent | 105 | 108 | 116 | 102 | 58 | 63 | 62 | 64 | 63 | 63 | 63 | 49 | |||||
Liabilities | 1,134 | 1,138 | 1,157 | 949 | 891 | 892 | 870 | 913 | 886 | 835 | 823 | 785 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Additional Paid In Capital Common Stock | 893 | 888 | 871 | 845 | 821 | 818 | 797 | 776 | 756 | 758 | 744 | 730 | |||||
Treasury Stock Common Value | -477 | -477 | -376 | -275 | -175 | -175 | -75 | -75 | -75 | -75 | -75 | -75 | |||||
Retained Earnings Accumulated Deficit | 798 | 680 | 625 | 598 | 519 | 446 | 458 | 327 | 265 | 134 | 30 | -102 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -2 | -1 | -2 | -1 | -2 | -2 | -1 | -1 | -1 | -1 | -1 | -1 | |||||
Stockholders Equity | 1,212 | 1,090 | 1,119 | 1,167 | 1,164 | 1,088 | 1,180 | 1,027 | 946 | 816 | 699 | 553 | |||||
Liabilities And Stockholders Equity | 2,347 | 2,227 | 2,276 | 2,116 | 2,055 | 1,980 | 2,050 | 1,940 | 1,831 | 1,651 | 1,522 | 1,338 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | |||||
Common Stock Shares Issued | 72 | 72 | 72 | 72 | 72 | 71 | 71 | 71 | 71 | 70 | 70 | 70 | |||||
Shares Outstanding | 65 | 65 | 72 | 72 | 72 | 68 | 71 | 71 | 71 | 70 | 70 | 70 | |||||
Treasury Stock Common Shares | 7 | 7 | 5 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 9.12% | 20.66% | 15.19% | - | - | - | - | - | - | - | - | - |
| 2025 | -6.12% | 1.24% | -9.39% | 5.84% | -2.43% | 8.08% | 9.65% | 24.25% | 25.74% | 1.33% | 11.12% | 24.50% |
| 2024 | 0.05% | 1.18% | 49.39% | 2.22% | 4.98% | 11.31% | -2.08% | 0.99% | 6.94% | 4.78% | 8.65% | -12.88% |
| 2023 | - | - | - | -9.16% | -15.38% | -4.72% | 10.71% | -4.13% | -14.61% | -10.58% | -6.55% | 16.86% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.83 | 2.70 | 2.67 | 4.29 | 5.74 | 5.52 | 1.65 | 4.68 | 4.84 | 5.80 | 5.37 | 4.88 | |||||
| Quick Ratio | 2.64 | 2.51 | 2.49 | 4.07 | 5.46 | 5.23 | 1.56 | 4.41 | 4.55 | 5.45 | 5.05 | 4.55 | |||||
| Working Capital | 609.12M | 566.55M | 578.25M | 921.68M | 1.18B | 1.09B | 511.64M | 967.86M | 911.60M | 898.47M | 771.83M | 598.18M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.94 | 1.04 | 1.03 | 0.81 | 0.77 | 0.82 | 0.74 | 0.89 | 0.94 | 1.02 | 1.18 | 1.42 | |||||
| Interest Coverage TTM | 14.64 | 15.74 | 17.63 | 22.25 | 23.07 | 23.23 | 24.44 | 23.17 | 24.17 | 18.21 | 3.16 | 2.04 | |||||
| Debt Ratio | 0.48 | 0.51 | 0.51 | 0.45 | 0.43 | 0.45 | 0.42 | 0.47 | 0.48 | 0.51 | 0.54 | 0.59 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.70 | 0.73 | 0.71 | 0.75 | 0.79 | 0.84 | 0.84 | 0.88 | 0.86 | 0.87 | 0.92 | 0.96 | |||||
| Days Sales Outstanding TTM | 83.14 | 80.49 | 81.41 | 85.07 | 81.49 | 72.05 | 71.76 | 79.77 | 77.44 | 70.06 | 69.10 | 71.92 | |||||
| Receivables Turnover TTM | 4.39 | 4.53 | 4.48 | 4.29 | 4.48 | 5.07 | 5.09 | 4.58 | 4.71 | 5.21 | 5.28 | 5.07 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 4.24 | 3.41 | 2.48 | 3.85 | 3.56 | 4.36 | 5.85 | 6.07 | 6.57 | 4.65 | 1.49 | 0.47 | |||||
| Free Cash Flow Per Share TTM | 5.83 | 5.25 | 6.16 | 6.99 | 6.89 | 7.13 | 6.51 | 5.69 | 4.05 | 3.79 | 3.79 | 3.58 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 60.48% | 61.10% | 62.23% | 63.75% | 64.04% | 64.43% | 64.78% | 64.49% | 64.02% | 54.73% | 53.65% | 52.83% | |||||
| Operating Profit Margin TTM | 18.76% | 20.16% | 22.77% | 28.78% | 29.44% | 29.79% | 32.11% | 31.93% | 35.19% | 28.13% | 4.60% | 2.57% | |||||
| Net Profit Margin TTM | 18.05% | 15.15% | 10.99% | 17.82% | 16.55% | 20.37% | 28.57% | 29.80% | 33.72% | 25.20% | 8.63% | 2.97% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 0.62% | 0.50% | 1.95% | 5.75% | 12.53% | 18.32% | 24.15% | 27.83% | 32.98% | 38.65% | 50.43% | 69.36% | |||||
| Net Income Growth (1Y) | 9.72% | -25.25% | -60.79% | -36.75% | -44.78% | -4.35% | 310.79% | 1,183.98% | -2,701.59% | 1,063.86% | -2.75% | 3.03% | |||||
| EPS Growth (1Y) | 16.39% | -23.35% | -59.48% | -35.98% | -44.71% | -5.64% | 304.71% | 1,165.74% | -2,663.45% | 1,067.63% | -2.29% | 3.49% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 17.60 | 19.23 | 20.56 | 20.70 | 26.36 | 19.81 | 17.83 | 13.00 | 9.29 | 12.96 | 45.68 | 171.94 | |||||
| P/B TTM | 4.05 | 4.12 | 3.08 | 4.81 | 5.76 | 5.69 | 6.46 | 5.42 | 4.53 | 5.19 | 6.80 | 10.38 | |||||
| P/S TTM | 3.18 | 2.91 | 2.26 | 3.69 | 4.36 | 4.04 | 5.09 | 3.87 | 3.13 | 3.26 | 3.94 | 5.10 | |||||
| Market Cap | 4.91B | 4.49B | 3.45B | 5.61B | 6.70B | 6.19B | 7.62B | 5.57B | 4.28B | 4.23B | 4.75B | 5.74B | |||||
| Enterprise Value | 4.98B | 4.70B | 3.63B | 5.48B | 6.33B | 5.84B | 7.32B | 5.38B | 4.12B | 4.08B | 4.70B | 5.88B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 377.11M | 354.05M | 414.02M | 478.61M | 473.01M | 493.13M | 451.98M | 394.85M | 278.34M | 258.71M | 259.12M | 244.48M | |||||
| Net Debt | 70.11M | 210.30M | 185.10M | -129.62M | -373.37M | -348.23M | -302.72M | -192.96M | -156.72M | -152.79M | -54.47M | 143.94M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Lantheus Holdings, Inc. (LNTH) — SEC Financial Statements & Analysis
Lantheus Holdings, Inc. (LNTH) is a in vitro & in vivo diagnostic substances company, incorporated in DE. Lantheus Holdings, Inc. trades on LNTH: Nasdaq as: LNTH. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Lantheus Holdings, Inc. reported a 0.62% year-over-year revenue growth, a Gross Profit Margin of 60.48% (TTM), a Debt-to-Equity ratio of 0.94x, a Price-to-Sales (P/S) ratio of 3.18x (TTM), a Price-to-Book (P/B) ratio of 4.05 (TTM), at a market cap of $4.91B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 0.62%
- Gross Profit Margin TTM
- 60.48%
- Debt To Equity
- 0.94x
- P/S TTM
- 3.18x
- P/B TTM
- 4.05
- Market Cap
- $4.91B
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Lantheus Holdings, Inc. in?
Lantheus Holdings, Inc. (LNTH) operates in the In Vitro & In Vivo Diagnostic Substances industry.
What is LNTH's market cap?
Lantheus Holdings, Inc. (LNTH) has a market capitalization of $4.91B as of 2026-03-31.
What is LNTH's P/E ratio?
Lantheus Holdings, Inc. (LNTH)'s trailing twelve month P/E ratio is 17.60x as of 2026-03-31.
What exchange does LNTH trade on?
Lantheus Holdings, Inc. (LNTH) trades on the LNTH: Nasdaq.
Where is Lantheus Holdings, Inc. incorporated?
Lantheus Holdings, Inc. is incorporated in DE.